Back to results
CompletedPhase 3

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

NCT03429543

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Phoenix Children's Hospital

Phoenix, Arizona, United States

+82 additional locations

View on ClinicalTrials.gov
Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM — TrialFind